Acesion Pharma announces Nature Medicine publication of clinical results in Atrial Fibrillation

COPENHAGEN, Denmark, Dec. 13, 2023. Acesion Pharma ( " Acesion " or " the Company " ), a biotech company pioneering first-in-class novel therapies for atrial fibrillation ( " AF " ), the most common cardiac arrhythmia, today announces the publication of data...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials